Pathology Challenges: Stephanie Evans is Leading the Fight Against Cancer
A leader in the health care industry in the sector of pathology, Stephanie Evans, Chief Operating Officer of PathNet, Inc., has experience and expertise that has been proven essential during the COVID-19 pandemic. Evans, an energetic businesswoman with a busy schedule, travels to various PathNet laboratory network locations and client facilities across the country. Her goal, primarily, is to have successful employee relationships and customer satisfaction.
In her role as COO, Evans leads a diverse team of professionals, with the aim to give providers accurate results for patients within 72 hours of procedure. While supervising multi-state laboratory personnel, Evans also manages top-tier pathologists. With time being a crucial factor in determining ideal treatment options for patients, innovative processes are at the top of her priorities.
For Evans, leading her team by empowering them to reach their potential is of greater emphasis than micromanaging.
Evans has seen innovation in pathology continuously within her 20 years of experience.
“Pathology is moving away from the old methods into a new enhanced digital pathology solution,” Evans says. “This shift is disrupting the pathology market — not just on the clinical level, but also the financial level.”
In the fight against cancer, advances in anatomic pathology along with molecular and germline testing are vital weapons. With the combination of results from each of these, professionals can best determine treatment plans for each patient. Through using digital pathology, health care professionals can readily share information from their findings. Pathology networks allow for this innovation to happen.
While laboratories are on the forefront of innovation, smaller pathology labs are facing challenges. Common issues include the inability to expand services because of organizational and reimbursement constraints. With reimbursement cuts, there is a decline in the possibility to invest in advanced equipment and hiring additional staff, which is essential for growth, while making workload increases necessary in order to break even.
PathNet, Inc. was created as a network of independent pathology groups with different models. With each group, there is a co-owner in a shared network of laboratories. Within the laboratory network, pathologists have access to the latest resources and best technology. PathNet also welcomes patient-facing physicians who are looking for cutting-edge pathology services so they can give the best patient care.
While Evans is a leader on her own, many of her colleagues have inspired her to become the greatest version of herself. Among these colleagues and mentors is E. Scot Davis, the CEO of Arkansas Urology, which is the largest urology practice in the state. When Evans served as Chief Clinical Services Officer at Arkansas Urology, she worked directly with Davis for day-to-day clinic management, along with large-scale projects. In recognizing Evans’ resilience, Davis challenged her to reach her goals. The experience and wisdom Evans gained during her tenure at Arkansas Urology is invaluable in her current role at PathNet, Inc.
Evans has also worked alongside Dr. Adam Cole, CMO of TruCore Pathology, since 2015, when they both joined the Arkansas Urology laboratory team. Evans’ lab experience, as well as her extensive knowledge of operations and billing, were a perfect match to assist Cole when it came time to build his own pathology practice, TruCore Pathology.
In 2017, Evans met Matthew Leavitt, MD, and at that time CEO of Lumea, Inc., when Arkansas Urology invested in Lumea’s cutting-edge pathology technology. In collaborating with Leavitt and the Lumea executive team as they expanded the company’s software capabilities, Evans and Leavitt discussed his visions of a pathology network. Alongside Leavitt’s vision and leadership, as well as Evans’ laboratory operations expertise, the skillsets were combined in 2020 to bring PathNet, Inc. to life, where Leavitt is now CEO.
Looking forward to growing the PathNet, Inc. network, Evans has made plans including collaborating with top-notch industry professionals while striving to consult with virtual labs across multiple states.
Accurate diagnosis will continue to play an essential role in patient treatment pathways until cancer has a definitive cure, and Evans will keep doing her part in helping patients get the most accurate diagnosis possible.
READ MORE: Go Red for Women — the Survivors










